These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1990552)

  • 1. Should cyclosporine be continued indefinitely?
    Stiller CR; Opelz G
    Transplant Proc; 1991 Feb; 23(1 Pt 1):36-40. PubMed ID: 1990552
    [No Abstract]   [Full Text] [Related]  

  • 2. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
    Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts.
    Collier DS; Calne RY; De Curtins M; Thiru S; White DJ; Jamieson NV; Thick M; Barroso E
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1279-80. PubMed ID: 3274318
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
    Venkat KK; Kupin W; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of cyclosporine in cardiac transplantation.
    Miller LW; Pennington DG; McBride LR
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):15-20. PubMed ID: 2349734
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of different parameters for the monitoring of cyclosporine.
    Humbert H; Vernillet L; Cabiac MD; Barradas J; Billaud E
    Transplant Proc; 1990 Jun; 22(3):1210-5. PubMed ID: 2349682
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 8. Elective cyclosporine conversion from triple therapy.
    Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 10. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 11. Current results with triple therapy for heart transplantation.
    Bolman RM; Olivari MT; Saffitz J; Sibley R; Spadaro J; Cance C; Elick B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2490-1. PubMed ID: 3274544
    [No Abstract]   [Full Text] [Related]  

  • 12. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
    Lloveras J; Masramon J; Orfila A; Cuevas X; Aubia J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2027-8. PubMed ID: 2978888
    [No Abstract]   [Full Text] [Related]  

  • 13. Fractional excretion of sodium during pulses of methylprednisolone for treatment of acute rejection in heart and kidney transplants.
    Lloveras JJ; Tran Van T; Magues JP; Bernadet P; Durand D; Suc JM
    Transplant Proc; 1990 Aug; 22(4):1384-5. PubMed ID: 2389337
    [No Abstract]   [Full Text] [Related]  

  • 14. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
    Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
    Kootte AM; van Dorp WT; van Bockel JH; van Es LA; Paul LC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.
    Bauma WD; Tang IY; Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal of methylprednisolone at the sixth month in renal transplant recipients treated with cyclosporine.
    Cristinelli L; Brunori G; Setti G; Manganoni A; Manganoni AM; Scolari F; Sandrini S; Scaini PS; Savoldi S; Camerini C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2021-3. PubMed ID: 3079069
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
    Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival.
    Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):152-4. PubMed ID: 3291231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.